CN105148213A - 一种治疗脂肪肝的中药 - Google Patents
一种治疗脂肪肝的中药 Download PDFInfo
- Publication number
- CN105148213A CN105148213A CN201510723238.1A CN201510723238A CN105148213A CN 105148213 A CN105148213 A CN 105148213A CN 201510723238 A CN201510723238 A CN 201510723238A CN 105148213 A CN105148213 A CN 105148213A
- Authority
- CN
- China
- Prior art keywords
- fatty liver
- radix
- chinese medicine
- traditional chinese
- liver
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 20
- 206010019708 Hepatic steatosis Diseases 0.000 title claims abstract description 19
- 208000004930 Fatty Liver Diseases 0.000 title claims abstract description 18
- 208000010706 fatty liver disease Diseases 0.000 title claims abstract description 18
- 231100000240 steatosis hepatitis Toxicity 0.000 title claims abstract description 18
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims abstract description 7
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 claims abstract description 7
- 239000000463 material Substances 0.000 claims description 3
- 230000000694 effects Effects 0.000 abstract description 4
- 230000006872 improvement Effects 0.000 abstract description 2
- 241000132012 Atractylodes Species 0.000 abstract 1
- 235000014493 Crataegus Nutrition 0.000 abstract 1
- 241001092040 Crataegus Species 0.000 abstract 1
- 244000164480 Curcuma aromatica Species 0.000 abstract 1
- 235000003398 Curcuma aromatica Nutrition 0.000 abstract 1
- 241001522129 Pinellia Species 0.000 abstract 1
- 244000299790 Rheum rhabarbarum Species 0.000 abstract 1
- 235000009411 Rheum rhabarbarum Nutrition 0.000 abstract 1
- 241000304195 Salvia miltiorrhiza Species 0.000 abstract 1
- 235000011135 Salvia miltiorrhiza Nutrition 0.000 abstract 1
- 240000006079 Schisandra chinensis Species 0.000 abstract 1
- 235000008422 Schisandra chinensis Nutrition 0.000 abstract 1
- 231100000331 toxic Toxicity 0.000 abstract 1
- 230000002588 toxic effect Effects 0.000 abstract 1
- 239000008280 blood Substances 0.000 description 16
- 210000004369 blood Anatomy 0.000 description 15
- 210000004185 liver Anatomy 0.000 description 11
- 208000024891 symptom Diseases 0.000 description 8
- 201000010099 disease Diseases 0.000 description 7
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 7
- 235000013305 food Nutrition 0.000 description 7
- 238000000034 method Methods 0.000 description 4
- 230000001737 promoting effect Effects 0.000 description 4
- 210000000952 spleen Anatomy 0.000 description 4
- 206010062717 Increased upper airway secretion Diseases 0.000 description 3
- 208000002193 Pain Diseases 0.000 description 3
- 230000037396 body weight Effects 0.000 description 3
- 235000009508 confectionery Nutrition 0.000 description 3
- 235000005911 diet Nutrition 0.000 description 3
- 230000037213 diet Effects 0.000 description 3
- 150000002148 esters Chemical class 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 208000026435 phlegm Diseases 0.000 description 3
- 240000006394 Sorghum bicolor Species 0.000 description 2
- 235000007230 Sorghum bicolor Nutrition 0.000 description 2
- 230000002159 abnormal effect Effects 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 230000036772 blood pressure Effects 0.000 description 2
- 208000027499 body ache Diseases 0.000 description 2
- 239000002934 diuretic Substances 0.000 description 2
- 230000001882 diuretic effect Effects 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 239000003172 expectorant agent Substances 0.000 description 2
- 230000003419 expectorant effect Effects 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 235000013372 meat Nutrition 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 208000037920 primary disease Diseases 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 238000005728 strengthening Methods 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 238000002604 ultrasonography Methods 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 241000251468 Actinopterygii Species 0.000 description 1
- 208000022309 Alcoholic Liver disease Diseases 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 208000023275 Autoimmune disease Diseases 0.000 description 1
- 208000008964 Chemical and Drug Induced Liver Injury Diseases 0.000 description 1
- 239000003390 Chinese drug Substances 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 206010013647 Drowning Diseases 0.000 description 1
- 206010072268 Drug-induced liver injury Diseases 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 206010019668 Hepatic fibrosis Diseases 0.000 description 1
- 206010019799 Hepatitis viral Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 208000001145 Metabolic Syndrome Diseases 0.000 description 1
- 244000061176 Nicotiana tabacum Species 0.000 description 1
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 1
- 201000002451 Overnutrition Diseases 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 102000003929 Transaminases Human genes 0.000 description 1
- 108090000340 Transaminases Proteins 0.000 description 1
- 201000000690 abdominal obesity-metabolic syndrome Diseases 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 230000010100 anticoagulation Effects 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 208000019425 cirrhosis of liver Diseases 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 201000008865 drug-induced hepatitis Diseases 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 235000013861 fat-free Nutrition 0.000 description 1
- 239000003337 fertilizer Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 210000003494 hepatocyte Anatomy 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000007102 metabolic function Effects 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 235000020823 overnutrition Nutrition 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- 230000001131 transforming effect Effects 0.000 description 1
- 201000001862 viral hepatitis Diseases 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
本发明涉及一种治疗脂肪肝的中药,是由柴胡、炒白芍、郁金、半夏、白术、生山楂、五味子、丹参、云苓、泽泻、川军按一定重量配比组成,治疗脂肪肝疗效显著,无毒副作用,总有效率100%,治愈率95%,好转率5%。
Description
技术领域:
本发明涉及一种治疗脂肪肝的中药,属于中药技术领域。
背景技术:
脂肪肝是多种原因引起的肝脏脂肪变性,进一步发展可导致脂肪性肝炎、肝纤维化、肝硬化、甚至肝癌的发生。随着生活水平的不断提高和社会的发展,脂肪肝日益成为现代社会的常见病、多发病。而且成为威胁人类健康的又一大类疾病。笔者近几年用本方治疗脂肪肝获得满意效果。
脂肪肝中医尚无此病名,据临床症状及体征属于胁疼、积聚、肥气、肝着、痰浊等范围。本病多由于过食肥甘厚味,懒言少气,或感受湿热疫毒,情志不畅,损伤肝脾功能所致。常见于中老年人、肥胖者,嗜食高梁厚味者。《素问·阴阳应象大论》曰:“年四十,而阴气自衰也,起居衰也,年五十,体重耳目不聪明矣…。”中年以后,人体由盛转衰,代谢功能逐渐下降,其人水湿不运,痰瘀渐生,以致身体肥盛,嗜食高梁厚味,营养过剩,致肝细胞内TG异常堆积,变生脂肪肝。祖国医学认为,脂肪肝的重要病机是脾胃运化失职,疾湿内阻于中焦,肝胆疏泄失常,升降失职,疾浊气阻,久而成瘀,痰瘀互结而成。
发明内容:
为解决上述问题,本发明提供了一种处方用药,用疏肝健脾、理气化瘀的方法治疗本病,疗效显著,无毒副作用。
一种治疗脂肪肝的中药,其特征在于它是由下列重量配比的原料药物的组分组成:柴胡10-12g、炒白芍12-15g、郁金10-12g、半夏6-9g、白术12-15g、生山楂12-15g、五味子12-15g、丹参20-30g、云苓12-15g、泽泻10-12g、川军1-3g。
优选用量:柴胡12g、炒白芍15g、郁金12g、半夏9g、白术15g、生山楂15g、五味子15g、丹参30g、云苓15g、泽泻12g、川军3g。
药理分析:柴胡,辛,寒,疏肝解郁,明显的保肝、降血脂、利胆。炒白芍,性微寒,味酸、养血柔肝、缓急止疼、保肝,降血脂,郁金、辛、苦、寒、活血止疼、行气解郁、降血脂、抗凝血、抗细胞氧化、抗动脉硬化、抗感染、抗肿瘤。半夏辛热燥湿化痰。白术、云苓,甘,淡微温,健脾燥湿利水。生山楂、甘,酸,微温,消积化痰、行气化瘀,善于消肉积。五味子,酸,温,现代医学实验有明显的降低转氨酶作用。丹参,苦,微寒,活血化瘀,养心安神,能促进肝细泡功能恢复,对肝细泡有良好的保护作用。泽泻,甘,淡,利水,渗湿,泄热,提取物对高血酯有防治作用。川军,苦,寒,泻火,通便,化瘀,有保肝通便作用。
剂型和服药方法:在控制饮食和适量增加运动的基础上服用本方,本发明中药剂型为汤剂,常规方法加水煎煮两次,第一遍煎煮30分钟,第二遍煎煮20分钟,两次药液混合过滤共得400毫升,早晚各200毫升饭前分服,服药期间忌食辛,辣及油腻食物。
具体实施方法:下面结合具体实施方法,对本发明做具体说明。
实施例1:一种治疗脂肪肝的中药,是由下列原料药物及重量配比制成:柴胡10-12、炒白芍12-15g、郁金10-12g、半夏6-9g、白术12-15g、生山楂12-15g、五味子12-15g、丹参20-30g、云苓12-15g、泽泻10-12g、川军1-3g。
实施例2:一种治疗脂肪肝的中药,其中各种原料药物的优先重量配比为:柴胡12g、炒白芍15g、郁金12g、半夏9g、白术15g、生山楂15g、五味子15g、丹参30g、云苓15g、泽泻12g、川军3g。
临床疗效总结:
一、一般资料
本发明方药临床运用多年,共治疗106例患者,男性多于女性,年龄在30-70岁之间,其中男性70例,女性36例。
二、诊断标准
1、临床症状:恶心、乏力、胁疼、厌油腻。
、肝脏彩超示:溺漫性脂肪肝。
、存在代谢综合症或者不明原因血清,水平增高持续4周以上。
、减肥后异常酶消失,脂肪肝改善甚至恢复正常。
、临床检验,血酯升高。
三、排除标准
酒精性肝病,病毒性肝炎,自身免疫性疾病,药物性肝炎。
四、疗效评定标准
1、治愈:临床症状消失,体重指数正常,彩超示无脂肪肝,血酯正常,随访1年未复发。
、有效:临床症状减轻,各项指标有所改善。
、无效:临床症状及各种体征均无改变。
五、治疗效果
服药2个月为一个疗程,服药一月后各种症状及体征均有明显好转,继服1月后,各种症状及指标均恢复正常,总有效率100%,治愈率95%,好转率5%。
典型病例:
李xx,男,45岁,自由职业,2012年5月就诊,自述,近几年体重明显增加,血压时有升高,乏力,时有胁疼,厌油腻食物,经现代医学诊断为;脂肪肝,高血压。平时嗜好烟酒,喜食鱼,肉及油腻食物,服用西药,降脂,降压药,未见明显好转,故来要求服用中药。查体;体胖,舌质稍暗苔腻边有齿龈,脉沉细滑,给服本药1月,并建议适当控制饮食,增加运动量,复诊时明显好转,继服1月后,症状完全消失,体重基本恢复正常,血压正常,不再服用降脂,降压药,随访1年未复发。
Claims (1)
1.一种治疗脂肪肝的中药,其特征在于它是由下列重量配比的原料药物的组分组成:柴胡10-12g、炒白芍12-15g、郁金10-12g、半夏6-9g、白术12-15g、生山楂12-15g、五味子12-15g、丹参20-30g、云苓12-15g、泽泻10-12g、川军1-3g。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510723238.1A CN105148213A (zh) | 2015-10-29 | 2015-10-29 | 一种治疗脂肪肝的中药 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510723238.1A CN105148213A (zh) | 2015-10-29 | 2015-10-29 | 一种治疗脂肪肝的中药 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN105148213A true CN105148213A (zh) | 2015-12-16 |
Family
ID=54789474
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510723238.1A Pending CN105148213A (zh) | 2015-10-29 | 2015-10-29 | 一种治疗脂肪肝的中药 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105148213A (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114558099A (zh) * | 2022-03-29 | 2022-05-31 | 沈阳市第六人民医院 | 中药组合物及其制备方法和应用 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1435249A (zh) * | 2003-03-14 | 2003-08-13 | 蒋盘宏 | 治疗高血脂和脂肪肝的中成药及制备方法 |
CN102233119A (zh) * | 2010-05-08 | 2011-11-09 | 博安兄弟制药(中国)有限公司 | 一种治疗脂肪肝的中药组合物及其制备方法 |
-
2015
- 2015-10-29 CN CN201510723238.1A patent/CN105148213A/zh active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1435249A (zh) * | 2003-03-14 | 2003-08-13 | 蒋盘宏 | 治疗高血脂和脂肪肝的中成药及制备方法 |
CN102233119A (zh) * | 2010-05-08 | 2011-11-09 | 博安兄弟制药(中国)有限公司 | 一种治疗脂肪肝的中药组合物及其制备方法 |
Non-Patent Citations (2)
Title |
---|
张新平: "疏肝化脂汤治疗脂肪肝对照观察", 《实用中医内科杂志》 * |
路长岭: "自拟疏肝化浊汤治疗非酒精性脂肪肝68例", 《中医杂志》 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114558099A (zh) * | 2022-03-29 | 2022-05-31 | 沈阳市第六人民医院 | 中药组合物及其制备方法和应用 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103007191B (zh) | 一种治疗黄疸的中药组合物 | |
CN103656535B (zh) | 一种治疗高脂血症的中药组合物及其制备方法 | |
CN102861298A (zh) | 一种治疗慢性胃炎的中药组合物 | |
CN104127531A (zh) | 一种治疗肠胃炎的中药组合物及其制备方法 | |
CN104940784A (zh) | 一种治疗慢性胃炎的中药组合物 | |
CN102198203B (zh) | 治疗非酒精性脂肪性肝病的中药 | |
CN103341035A (zh) | 柴胡降脂汤 | |
CN103142944B (zh) | 一种治疗酒精肝的中药组合物 | |
CN113713030A (zh) | 一种治疗脂肪肝的中药组方 | |
CN102430105B (zh) | 一种治疗慢性胃炎的中药组合物 | |
CN102091288A (zh) | 一种治疗脂肪肝的中药制剂及其制备方法 | |
CN105148213A (zh) | 一种治疗脂肪肝的中药 | |
CN104771657A (zh) | 一种治疗胃溃疡的中药组合物 | |
CN103100063B (zh) | 一种治疗湿热型胆囊结石的中药 | |
CN102106992B (zh) | 一种治疗非酒精性脂肪性肝炎的中药颗粒 | |
CN113171415A (zh) | 一种治疗非酒精性脂肪肝的中药组合物 | |
CN106074918A (zh) | 一种治疗非酒精性脂肪性肝病的疏肝消脂中药组合物 | |
CN101700392B (zh) | 一种治疗肥胖性脂肪肝的中药组合物 | |
CN115554379B (zh) | 软肝化瘀颗粒 | |
CN102784317B (zh) | 一种治疗口疮的中药组合物 | |
CN103405574A (zh) | 一种治疗高血压的药物组合物 | |
CN103638441B (zh) | 一种治疗肝郁脾虚型脂肪肝的中药组合物 | |
CN102233004B (zh) | 一种治疗肝病的药物 | |
CN101081293A (zh) | 一种用于预防与治疗肝病之门静脉通瘀胶囊制剂 | |
CN105561001A (zh) | 一种治疗酒精性肝炎的中药组合物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20151216 |
|
WD01 | Invention patent application deemed withdrawn after publication |